Mylan appeals loss to Sun Pharma over cholesterol drug patent
Ashurst 2019-02-14 11:31 am By Cat Fredenburgh | Melbourne
Please login to bookmark Close

Mylan has appealed a ruling invaliding claims of its cholesterol drug patent and dismissing its patent infringement case against Sun Pharma.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au